Regen BioPharma Inc
OTC:RGBP

Watchlist Manager
Regen BioPharma Inc Logo
Regen BioPharma Inc
OTC:RGBP
Watchlist
Price: 0.0084 USD -16% Market Closed
Market Cap: 865.6k USD

EV/EBITDA
Enterprise Value to EBITDA

-3.8
Current
-66.8
Median
11.1
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-3.8
=
Enterprise Value
1.1m USD
/
EBITDA
-300.9k USD
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
US
Regen BioPharma Inc
OTC:RGBP
Average EV/EBITDA: 46 853.8
Negative Multiple: -3.8
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
S
Suncast Solar Energy Inc
OTC:SUNC
Negative Multiple: -619 939 312.5 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
IN
S
SAB Industries Ltd
BSE:539112
183 820.1
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
R
Reddit Inc
NYSE:RDDT
149.3
N/A N/A
US
Coupang Inc
F:788
28.6
57%
0.5
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 094.4 N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A